Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.7 |
mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |